As research progresses, we may find that semaglutide offers a new, effective option for managing psoriasis, particularly for patients who are overweight or have other health conditions like diabetes
Rapid weight loss has been associated with gallbladder-related disorders including cholelithiasis and cholecystitis [67, 68], and these adverse events, while rare, have been observed more with GLP-1RAs compared with placebo in clinical trials [21, 38]
PubMed Tkalcevic, V.I., Cuzic, S., Brajsa, K., Mildner, B., Bokulic, A., Situm, K., Perovic, D., Glojnaric, I., Parnham, M.J
Approximately 15-20% of trial participants across both medications achieved what researchers term super-responder status, exceeding 30% weight loss